Suppression of LSD1 enhances the cytotoxic and apoptotic effects of regorafenib in hepatocellular carcinoma cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Suppression of LSD1 enhances the cytotoxic and apoptotic effects of regorafenib in hepatocellular carcinoma cells

Published:2019-05 Issue:4 Volume:512 Page:852-858
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Wu Lin-wen,Zhou Dong-mei,Zhang Zuo-yan,Zhang Jian-kang,Zhu Hua-jian,Lin Neng-ming,Zhang Chong

Funder

Zhejiang University City College

Hangzhou Major Science and Technology Project

Zhejiang Provincial Foundation of Natural Science

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference23 articles.

1. Hepatocellular carcinoma: where there is unmet need;Bupathi;Mol Oncol,2015

2. Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines;Ayuso;Eur. J. Radiol.,2018

3. Systemic therapy for advanced hepatocellular carcinoma: an update;Desai;J. Gastrointest. Oncol.,2017

4. Role of regorafenib as second-line therapy and landscape of investigational treatment options in advanced hepatocellular carcinoma;Trojan;J. Hepatocell. Carcinoma,2016

5. Precision diagnosis and treatment of liver cancer in China;Fu;Cancer Lett.,2018

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the relationship between histone methylation and nonalcoholic fatty liver disease;World Journal of Hepatology;2024-05-27

2. The emerging roles of histone demethylases in cancers;Cancer and Metastasis Reviews;2024-01-16

3. Lysine-specific demethylase 1 as a therapeutic cancer target: observations from preclinical study;Expert Opinion on Therapeutic Targets;2023-12-02

4. Pharmacological inhibition of LSD1 suppresses growth of hepatocellular carcinoma by inducing GADD45B;MedComm;2023-05-24

5. Lysine-Specific Demethylase 1 Promises to Be a Novel Target in Cancer Drug Resistance: Therapeutic Implications;Journal of Medicinal Chemistry;2023-04-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3